Search

Your search keyword '"Carcinoma -- Care and treatment"' showing total 113 results
Start Over Descriptor "Carcinoma -- Care and treatment" Topic medical research
113 results on '"Carcinoma -- Care and treatment"'

1. New Research on Nasopharyngeal Carcinoma from National Clinical Research Center for Respiratory Disease Summarized (Single-cell transcriptome analysis reveals evolving tumour microenvironment induced by immunochemotherapy in nasopharyngeal ...)

Subjects
Medical research, Medicine, Experimental, Lung diseases -- Care and treatment, Carcinoma -- Care and treatment, Cancer -- Care and treatment, Physical fitness
Abstract

2024 NOV 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on nasopharyngeal carcinoma have been published. According to news [...]

Published
2024

2. Can-Fite: Pancreatic Carcinoma Phase IIa Clinical Study With Namodenoson Received Regulatory Authorization from the Israeli Ministry of Health

Subjects
Can-Fite BioPharma Ltd. -- Product development, Medical research, Medicine, Experimental, Carcinoma -- Care and treatment, Drug approval, Clinical trials, Cancer -- Care and treatment, Pancreatic cancer -- Care and treatment, Pharmaceutical industry -- Product development, General interest, News, opinion and commentary
Abstract

PETACH TIKVA: Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced that [...]

Published
2024

3. New Findings from UConn Health Describe Advances in Cutaneous Mastocytosis (Radiotherapy-associated Cutaneous Mastocytosis In a Patient With Breast Carcinoma. Case Report and Review of the Literature)

Subjects
Medical research, Medicine, Experimental, Carcinoma -- Care and treatment, Skin, Cancer -- Care and treatment, Radiotherapy, Breast cancer -- Care and treatment, Mast cell disease -- Care and treatment, Health, Women's issues/gender studies
Abstract

2023 JUN 15 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Investigators discuss new findings in Skin Diseases and Conditions - Cutaneous Mastocytosis. According to [...]

Published
2023

4. First Patient Dosed with LIXTE's LB-100 and GSK's Immunotherapy Dostarlimab-gxly in the Ovarian Clear Cell Carcinoma Trial

Subjects
Medical research, Medicine, Experimental, Immunotherapy, Carcinoma -- Care and treatment, Cancer -- Care and treatment, Monoclonal antibodies, General interest, News, opinion and commentary
Abstract

PASADENA: LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT and LIXTW) (LIXTE or the Company), today announced the dosing of the first patient in a Phase 1b/2 clinical trial to assess whether [...]

Published
2024

5. Findings from Beth Israel Deaconess Medical Center Broaden Understanding of Urothelial Cancer (Management of Advanced Urothelial Carcinoma In Older and Frail Patients: Have Novel Treatment Approaches Improved Their Care?)

Subjects
Medical research, Medicine, Experimental, Aged patients -- Care and treatment, Medical centers, Carcinoma -- Care and treatment, Cancer -- Care and treatment, Physical fitness, Health, Beth Israel Deaconess Medical Center
Abstract

2022 APR 30 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Oncology - Urothelial Cancer have been published. According [...]

Published
2022

6. University Hospital Mohammed VI Researchers Have Published New Data on Cushing's Syndrome (Pediatric adrenocortical carcinoma revealed by isolated Cushing syndrome: A case report)

Subjects
Medical research, Medicine, Experimental, Carcinoma -- Care and treatment, Cushing syndrome -- Care and treatment, Children -- Health aspects, Cancer -- Care and treatment, Health
Abstract

2023 NOV 10 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- A new study on Cushing's syndrome is now available. According to news reporting [...]

Published
2023

7. Report Summarizes Nasopharyngeal Carcinoma Study Findings from Sun Yat-sen University (Stent Pretreatment for Internal Carotid Artery Exposed To Necrotic Lesions In Nasopharyngeal Carcinoma)

Subjects
Medical research, Medicine, Experimental, Stent (Surgery), Carcinoma -- Care and treatment, Cancer -- Care and treatment, Health
Abstract

2023 JUL 28 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators discuss new findings in Oncology - Nasopharyngeal Carcinoma. According to news reporting [...]

Published
2023

8. Can-Fite: 'Effects of Namodenoson on Pancreatic Carcinoma: Preclinical Evidence' Published Online

Subjects
Medical research, Medicine, Experimental, Cancer -- Prevention -- Care and treatment, Carcinoma -- Care and treatment, Liver cancer -- Care and treatment, Pancreatic cancer -- Care and treatment, Business, Business, international, Telecommunications industry
Abstract

Can-Fite BioPharma, a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncology, inflammatory and liver diseases, reported that its study titled, 'Effects of Namodenoson on Pancreatic [...]

Published
2023

9. Reports from Chang Gung University Advance Knowledge in Kidney Disease (Safety and Efficacy of Immune Checkpoint Inhibitors for Patients With Metastatic Urothelial Carcinoma and End-Stage Renal Disease: Experiences From Real-World Practice)

Subjects
Medical research, Medicine, Experimental, Chronic kidney failure -- Care and treatment, Metastasis -- Care and treatment, Carcinoma -- Care and treatment, Cancer -- Care and treatment, Physical fitness, Health
Abstract

2021 JAN 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in Kidney Diseases and Conditions - Kidney Disease. [...]

Published
2021

10. New Urothelial Cancer Data Have Been Reported by Investigators at AstraZeneca (Medical Oncology Referral and Systemic Therapy of Patients With Advanced Stage Urothelial Carcinoma)

Subjects
AstraZeneca PLC, Physical fitness, Medical research, Carcinoma -- Care and treatment, Epidemiology, Pharmaceutical industry, Health
Abstract

2020 OCT 24 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on Oncology - Urothelial Cancer is now available. According [...]

Published
2020

11. New Data from Karolinska Institute Illuminate Findings in Nasopharyngeal Carcinoma (Radiation Therapy-Induced Changes of the Nasopharyngeal Commensal Microbiome in Nasopharyngeal Carcinoma Patients)

Subjects
Physical fitness, Medical research, Radiotherapy, Carcinoma -- Care and treatment, Cancer patients -- Care and treatment, Antineoplastic agents, Radiation (Physics), Health
Abstract

2020 OCT 17 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Oncology - Nasopharyngeal Carcinoma have been published. According [...]

Published
2020

12. Studies from Southern Medical University Yield New Information about Nasopharyngeal Carcinoma (Long-term defects of nasal epithelium barrier functions in patients with nasopharyngeal carcinoma post chemo-radiotherapy)

Subjects
Physical fitness, Respiratory tract diseases -- Care and treatment, Chemotherapy, Medical research, Radiotherapy, Carcinoma -- Care and treatment, Medical schools, Epithelium, Recurrence (Disease), Cancer, Obesity, Infection, Epigenetic inheritance, Editors, Health
Abstract

2020 MAY 16 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Oncology - Nasopharyngeal Carcinoma. According to news [...]

Published
2020

13. Third Affiliated Hospital of Kunming Medical University Researchers Update Understanding of Carcinomas (Adaptor protein LNK promotes anaplastic thyroid carcinoma cell growth via 14-3-3 e/g binding)

Subjects
Physical fitness, Thyroid diseases -- Care and treatment, Cancer -- Care and treatment, Biochemistry, Medical research, Carcinoma -- Care and treatment, Thyroid gland, Obesity, Special funds, Editors, Health
Abstract

2020 FEB 1 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on carcinomas have been presented. According to news reporting originating [...]

Published
2020

14. Researchers at Department of Oncology Report New Data on Brain Metastasis (Combination Toripalimab and Bevacizumab for an Elderly Urothelial Carcinoma Patient With Brain Metastasis Who Failed Rapidly After Radiotherapy: a Case Report and ...)

Subjects
Brain research, Medical research, Medicine, Experimental, Aged patients -- Care and treatment, Metastasis -- Care and treatment, Immunotherapy, Brain tumors -- Care and treatment, Carcinoma -- Care and treatment, Chemotherapy, Cancer -- Care and treatment -- Chemotherapy, Radiotherapy, Health
Abstract

2023 MAR 29 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- A new study on Brain Diseases and Conditions - Brain Metastasis is now available. According [...]

Published
2023

15. Elevar Therapeutics Announced Rivoceranib Demonstrated Clinical Effectiveness in Patients with Progressive Recurrent or Metastatic Adenoid Cystic Carcinoma in a Phase 2 Trial

Subjects
Medical research, Medicine, Experimental, Metastasis -- Care and treatment, Diseases -- Relapse, Carcinoma -- Care and treatment, Clinical trials, Cancer -- Care and treatment, Business, international
Abstract

SALT LAKE CITY,: Elevar Therapeutics, Inc., a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for patients who have limited or inadequate therapeutic options, today announced its [...]

Published
2022

16. Bristol Myers Squibb receives positive CHMP opinion recommending approval for Opdivo (nivolumab) as adjuvant treatment for patients with radically resected, high-risk muscle-invasive urothelial carcinoma with tumour cell PD-L1 expression greater than or equal to 1%

Subjects
Bristol-Myers Squibb Co., Medical research, Medicine, Experimental, Diseases -- Relapse, Carcinoma -- Care and treatment, Clinical trials, Lung cancer, Non-small cell -- Care and treatment, Drug approval, Cancer -- Care and treatment, Pharmaceutical industry, Business, Chemicals, plastics and rubber industries, European Union, European Union. European Commission, Opdivo (Medication)
Abstract

Bristol Myers Squibb announced on 25 Feb 2022 that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Opdivo (nivolumab) for the adjuvant treatment of adults with muscle-invasive urothelial carcinoma with tumour cell PD-L1 expression greater than or equal to 1% who are at a high risk of recurrence after undergoing radical resection. The European Commission (EC), which has the authority to approve medicines for the European Union (EU), will now review the CHMP recommendation. The positive opinion is based on results from the Phase 3 CheckMate -274 study, which demonstrated a statistically significant and clinically meaningful increase in disease-free survival (DFS) with Opdivo compared to placebo in both all randomized patients and in patients whose tumor cells express PD-L1 greater than or equal to 1%. Opdivo is the first and only immunotherapy to significantly improve the median time patients lived without disease recurrence in a randomized, placebo-controlled clinical trial in this setting. Opdivo was generally well tolerated, with a safety profile that was consistent with previously reported Opdivo studies in patients with solid tumors. Results from CheckMate -274 were first presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium in Feb 2021 and published in the New England Journal of Medicine in Jun 2021. Opdivo received approval for the adjuvant treatment of patients with urothelial carcinoma who are at high risk of recurrence after undergoing radical resection, regardless of PD-L1 expression levels, in the United States in Aug 2021 and is currently undergoing regulatory reviews around the world. To date, Opdivo-based treatments have demonstrated clinically meaningful efficacy in four Phase 3 trials in earlier-stage cancers, including adjuvant bladder cancer, melanoma, esophageal/gastroesophageal junction cancer and neoadjuvant non-small cell lung cancer. Original source: Bristol-Myers Squibb, website: http://www.bms.com/, Copyright Bristol-Myers Squibb 2022., regulations and rulings; research and development; anticancer drugs; monoclonal antibodies; nivolumab; Opdivo; therapeutic antibodies; Bristol Myers [...]

Published
2022

17. Sichuan University Researchers Update Current Study Findings on Gallbladder Cancer (Remarkable Response of Metastatic Gallbladder Carcinoma to Apatinib After Failed Multiline Chemotherapies: A Case Report and Literature Review)

Subjects
Physical fitness, Cancer -- Care and treatment, Cancer research, Chemotherapy, Carcinoma -- Care and treatment, Gallbladder cancer -- Care and treatment, Cancer metastasis -- Care and treatment, Cancer treatment, Clinical trials, Medical research, Tumors, Obesity, Editors, Health
Abstract

2019 NOV 30 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in gallbladder cancer. According to news reporting originating [...]

Published
2019

18. Adjuvant radiotherapy in carcinoma buccal mucosa; more conformal the best: Is it so?

Author

Koushik, A., Sebastian, M., Janaki, M., and Sathish, S.

Subjects
Medical research, Carcinoma -- Care and treatment, Radiotherapy -- Usage, Radiation (Physics), Cancer, Health
Abstract

Byline: A. Koushik, M. Sebastian, M. Janaki, S. Sathish Introduction: Since 1980s, computerization has made improvements in radiation therapy delivery from conventional two-dimensional to three-dimensional conformal radiotherapy (2DCRT to 3DCRT) [...]

Published
2019

19. Zentalis Pharmaceuticals Announces First Patient Dosed in Potentially Registrational Phase 2 Study of ZN-c3 in Patients with Uterine Serous Carcinoma

Subjects
Medical research, Medicine, Experimental, Zinc compounds, Zinc, Carcinoma -- Care and treatment, Drug approval, Cancer -- Care and treatment, Business, international, Law
Abstract

(GlobeNewswire) - Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers, today announced that the first [...]

Published
2021

20. Zentalis Pharmaceuticals Announces First Patient Dosed in Potentially Registrational Phase 2 Study of ZN-c3 in Patients with Uterine Serous Carcinoma

Subjects
Medical research, Medicine, Experimental, Zinc compounds, Zinc, Carcinoma -- Care and treatment, Drug approval, Cancer -- Care and treatment, Banking, finance and accounting industries, Business
Abstract

NEW YORK and SAN DIEGO, Aug 02, 2021 (GLOBE NEWSWIRE via COMTEX) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics [...]

Published
2021

21. Zentalis Pharmaceuticals Announced First Patient Dosed in Potentially Registrational Phase 2 Study of ZN-c3 in Patients with Uterine Serous Carcinoma

Subjects
Medical research, Medicine, Experimental, Zinc compounds, Zinc, Carcinoma -- Care and treatment, Drug approval, Cancer -- Care and treatment, General interest, News, opinion and commentary
Abstract

NEW YORK and SAN DIEGO,; Zentalis Pharmaceuticals announced that the first patient has been dosed in the Phase 2 trial of ZN-c3, the Company's oral WEE1 inhibitor product candidate, in [...]

Published
2021

22. Studies from Guangdong General Hospital Reveal New Findings on Nasopharyngeal Carcinoma (Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma)

Subjects
Physical fitness, Chemotherapy, Medical research, Carcinoma -- Care and treatment, Magnetic resonance imaging, Health
Abstract

2018 JAN 20 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Oncology - Nasopharyngeal Carcinoma have been published. According [...]

Published
2018

23. A Phase II Study of Radiation Therapy with or without Avelumab in People with Advanced Merkel Cell Carcinoma

Subjects
Medical research, Medicine, Experimental, Metastasis -- Care and treatment, Immunotherapy, Radiation, Carcinoma -- Care and treatment, Clinical trials, Cancer -- Care and treatment, Business, international, Law
Abstract

A Phase II Randomized Parallel Two-Arm Clinical Trial Assessing Comprehensive Ablative Radiation Therapy with or without Avelumab in Unresectable and Metastatic Merkel Cell Carcinoma (CARTA) Purpose The purpose of this [...]

Published
2021

24. Assessing current treatment options for patients with severe/advanced basal cell carcinoma

Author

Weinstock, Martin A.

Subjects
Medical research, Medicine, Experimental, Tumors -- Care and treatment, Carcinoma -- Care and treatment, Cancer -- Care and treatment, Basal cell carcinoma -- Care and treatment, Health, Health care industry
Abstract

Skin cancers are the most common form of malignancy, and basal cell carcinoma (BCC) is the most common form of skin cancer. BCCs generally occur sporadically and either singly or [...]

Published
2012

25. Avelumab maintenance extends OS in advanced urothelial carcinoma

Subjects
Chemotherapy, Medical research, Avelumab, Carcinoma -- Care and treatment, Operating systems (Software), Cancer metastasis -- Care and treatment, Cancer treatment, Cancer, Combination drug therapy, 64-bit operating system, 32-bit operating system, Operating system, Business, international, Law
Abstract

The addition of maintenance avelumab to best supportive care extended OS for patients with previously untreated locally advanced or metastatic urothelial carcinoma, according to study results released by the agents [...]

Published
2020

27. Data from National University of Medical Sciences Advance Knowledge in Chronic Hepatitis C Virus (Frequency of Hepatocellular Carcinoma And Associated Sociodemographic Factors in Treated Patients of Chronic Hepatitis C)

Subjects
Medical research, Medicine, Experimental, Hepatitis C virus, Carcinoma -- Care and treatment, Cancer -- Care and treatment, Health
Abstract

2021 SEP 17 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- A new study on chronic hepatitis C virus is now available. According to [...]

Published
2021

28. Reports from Dana-Farber Cancer Institute Add New Data to Findings in Disease-Free Survival (Adjuvant Pembrolizumab After Nephrectomy In Renal-cell Carcinoma)

Subjects
Medical research, Medicine, Experimental, Immunotherapy, Carcinoma -- Care and treatment, Epidemiology, Cancer -- Care and treatment, Health
Abstract

2021 SEP 15 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Researchers detail new data in Epidemiology - Disease-Free Survival. According to news reporting out of [...]

Published
2021

29. Data on Nasopharyngeal Carcinoma Reported by Researchers at Sun Yat-sen University (Metronomic Capecitabine As Adjuvant Therapy In Locoregionally Advanced Nasopharyngeal Carcinoma: a Multicentre, Open-label, Parallel-group, Randomised, ...)

Subjects
Medical research, Medicine, Experimental, Capecitabine, Diseases -- Relapse, Carcinoma -- Care and treatment, Chemotherapy, Cancer -- Care and treatment -- Chemotherapy, Health
Abstract

2021 AUG 20 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Current study results on Oncology - Nasopharyngeal Carcinoma have been published. According to [...]

Published
2021

30. Exicure Reports Activity of AST-008 in Patients with Merkel Cell Carcinoma and Will Enroll Patients in Phase 2 Study

Subjects
Nucleic acids, Medical research, Carcinoma -- Care and treatment, Pembrolizumab, Genes, Technology, Cancer, Immunotherapy, Tumors, Business, Business, international
Abstract

- Phase 1b/2 dose escalation trial of AST-008 shows tolerability of Exicure drug candidate - Preliminary data show signs of activity in patients with Merkel cell carcinoma - Exicure to [...]

Published
2019

31. Data on Otitis Media Detailed by Researchers at Taichung Tzu Chi Hospital (Management Options for Patients With Nasopharyngeal Carcinoma Undergoing Cochlear Implantation)

Subjects
Medical research, Carcinoma -- Care and treatment, Deafness -- Care and treatment, Otitis media -- Care and treatment, Company business management, Health, Health care industry
Abstract

2020 DEC 6 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- A new study on Ear Diseases and Conditions - Otitis Media [...]

Published
2020

32. Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University Researchers Have Provided New Data on Endometrial Cancer (Recurrence-related Factors of 46 Stage I-II Endometrial Carcinoma Patients)

Subjects
Cancer -- Care and treatment, Endometrial cancer -- Care and treatment, Cancer research, Recurrence (Disease) -- Care and treatment, Carcinoma -- Care and treatment, Medical research, Editors, Health
Abstract

2020 MAY 11 (NewsRx) -- By a News Reporter-Staff News Editor at OBGYN & Reproduction Week -- Investigators publish new report on endometrial cancer. According to news originating from Nanjing, [...]

Published
2020

33. New Ovarian Cancer Study Findings Recently Were Reported by Researchers at Peter MacCallum Cancer Centre (Therapeutic options for mucinous ovarian carcinoma)

Subjects
Cancer treatment, Cancer research, Carcinoma -- Care and treatment, Ovarian cancer -- Care and treatment, Chemotherapy, Anopheles, Medical research, Finance, Editors, Diseases, Health
Abstract

2020 MAR 16 (NewsRx) -- By a News Reporter-Staff News Editor at OBGYN & Reproduction Week -- Data detailed on Oncology - Ovarian Cancer have been presented. According to news [...]

Published
2020

34. Reports from Department of Respiratory Disease Provide New Insights into Small Cell Lung Cancer (Silencing of heat shock protein 27 increases the radiosensitivity of non-small cell lung carcinoma cells)

Subjects
Small cell lung cancer -- Care and treatment, Carcinoma -- Care and treatment, Heat shock proteins, Lung diseases -- Care and treatment, Non-small cell lung cancer -- Care and treatment, Anopheles, Radiation (Physics), Medical research, Tumors, Respiratory tract diseases, Radiotherapy, Editors, Lung cancer, Business, Health, Health care industry
Abstract

2019 JUN 4 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Current study results on Oncology - Small Cell Lung Cancer have been published. According to [...]

Published
2019

35. Phase Ib Clinical Study on Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Patients With Advanced Biliary Adenocarcinoma/Hepatocellular Carcinoma

Subjects
Biliary tract cancer -- Care and treatment, Type 2 diabetes -- Care and treatment, Clinical trials, Medical research, Liver diseases -- Care and treatment, Carcinoma -- Care and treatment, Cancer, Editors, Health
Abstract

2019 FEB 18 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- Staff editors report on the newly launched clinical trial, NCT03825705, which has the following [...]

Published
2019

36. Reports by H. Takahashi and Co-Researchers Describe Recent Advances in Salivary Gland Cancer (Phase II Trial of Trastuzumab and Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2-Positive Salivary Duct Carcinoma)

Subjects
Trastuzumab -- Product development, Epidermal growth factors, Clinical trials, Cancer research, Docetaxel -- Product development, Carcinoma -- Care and treatment, Toxicity, Cancer, Biotechnology, Antineoplastic agents, Cancer metastasis, Editors, Medical research, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2019 JAN 23 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- Researchers detail new data in Oncology - Salivary Gland Cancer. According to news reporting originating [...]

Published
2019

37. Intraperitoneal Radioactive Phosphorus (32P) vs Observation After Negative Second-Look Laparotomy for Stage III Ovarian Carcinoma

Subjects
Ovarian cancer -- Care and treatment, Carcinoma -- Care and treatment, Cancer -- Care and treatment, Phosphates, Medical research, Medicine, Experimental, Surgery, Health
Abstract

Intraperitoneal Radioactive Phosphorus (32P) vs Observation After Negative Second-Look Laparotomy for Stage III Ovarian Carcinoma Abstract & Commentary Synopsis: Intraperitoneal chromic phosphate did not decrease the risk of relapse or [...]

Published
2003

38. Management of Invasive Carcinoma of the Uterine Cervix Associated with Pregnancy: Outcome in Intentional Delay in Treatment

Subjects
Carcinoma -- Care and treatment, Cancer -- Care and treatment, Infants (Premature) -- Care and treatment, Cervical cancer -- Care and treatment, Pregnant women -- Care and treatment, Cancer patients -- Care and treatment, Pregnancy, Medical research, Medicine, Experimental, Health
Abstract

Management of Invasive Carcinoma of the Uterine Cervix Associated with Pregnancy: Outcome in Intentional Delay in Treatment Abstract & Commentary Synopsis: Delay in treatment to allow for fetal maturity is [...]

Published
2003

40. Tekmira Provides Update on TKM-PLK1 Phase I/II Clinical Study in Patients With Advanced Gastrointestinal Neuroendocrine Tumors and Adrenocortical Carcinoma

Subjects
Medical research, Medicine, Experimental, Carcinoma -- Care and treatment, Clinical trials, Cancer -- Care and treatment, Banking, finance and accounting industries, Business
Abstract

VANCOUVER, British Columbia, Dec 31, 2014 (GLOBE NEWSWIRE via COMTEX) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, today provided a status update on [...]

Published
2014

41. Polaris Group Announces Treatment of First Patient in Phase 1 Study of ADI-PEG 20 plus Pemetrexed and Cisplatin in Malignant Pleural Mesothelioma And Non-Squamous Non-Small Cell Lung Carcinoma

Subjects
Medical research, Medicine, Experimental, Cisplatin -- Product development, Carcinoma -- Care and treatment, Mesothelioma -- Care and treatment, Clinical trials, Lung cancer, Non-small cell -- Care and treatment, Cancer -- Care and treatment, Business, News, opinion and commentary
Abstract

SAN DIEGO, Nov. 20, 2014 /PRNewswire/ -- Polaris Group announced today that the first patient has been dosed in its Phase 1 trial of ADI-PEG 20 in combination with pemetrexed [...]

Published
2014

43. Glycotope Doses First Patients in Phase IIb Study with PankoMab-GEX(TM) for the Maintenance Therapy of Ovarian Carcinoma

Subjects
Thomson Reuters Corp. -- Product development, Medical research, Medicine, Experimental, Antineoplastic agents -- Product development, Antigenic determinants, Information services industry -- Product development, Carcinoma -- Care and treatment, Cancer -- Care and treatment, Clinical trials, Information services -- Product development, Antimitotic agents -- Product development, Information services industry, Business, international
Abstract

(Thomson Reuters ONE via COMTEX) -- Glycotope GmbH / Glycotope Doses First Patients in Phase IIb Study with PankoMab-GEX(TM) for the Maintenance Therapy of Ovarian Carcinoma . Processed and transmitted [...]

Published
2013

44. Exelixis Inc release: Cabozantinib demonstrates encouraging activity in patients with heavily pretreated metastatic renal cell carcinoma

Subjects
Exelixis Inc., Medical research, Medicine, Experimental, Metastasis -- Care and treatment, Biotechnology industry, Carcinoma -- Care and treatment, Carcinoma, Renal cell -- Care and treatment, Cancer -- Care and treatment, Business, Chemicals, plastics and rubber industries
Abstract

Exelixis Inc has reported positive updated interim data from a cohort of heavily pretreated patients with metastatic refractory renal cell carcinoma (RCC) participating in an ongoing Phase Ib trial of [...]

Published
2012

45. OncoSec Initiates Phase II Merkel Cell Carcinoma Study and Doses Several Patients

Subjects
Medical research, Medicine, Experimental, Carcinoma -- Care and treatment, Cancer -- Care and treatment, Business, News, opinion and commentary, University of Washington
Abstract

SAN DIEGO, Feb. 13, 2012 /PRNewswire/ --http://www.oncosec.com/ (OTCBB: ONCS), which is developing its advanced-stage http://www.oncosec.com/technology/oncosec-medical-system ElectroOncology therapies to treat solid tumor cancers, today announced that physicians at the University of [...]

Published
2012

46. OncoSec initiates Phase II Merkel cell carcinoma study and doses several patients

Subjects
Medical research, Medicine, Experimental, Carcinoma -- Care and treatment, Cancer -- Care and treatment, Clinical trials, Business, Chemicals, plastics and rubber industries
Abstract

OncoSec Medical Inc (OncoSec), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumour cancers, announced that physicians at the University of Washington and Seattle [...]

Published
2012

47. Data from Central Hospital Provide New Insights into Genetic Research (Study on serum proteomic features in patients with and without recurrence or metastasis after surgical resection of esophageal carcinoma)

Subjects
Surgery, Recurrence (Disease) -- Care and treatment, Medical research, Carcinoma -- Care and treatment, Cancer metastasis -- Care and treatment, Esophageal cancer -- Care and treatment, Biological sciences, Health
Abstract

By a News Reporter-Staff News Editor at Life Science Weekly -- A new study on Life Science Research is now available. According to news reporting originating from Luoyang, People's Republic [...]

Published
2014

48. Polaris Group Announces Treatment of First Patient in Phase 1 Study of ADI-PEG 20 plus Pemetrexed and Cisplatin in Malignant Pleural Mesothelioma And Non-Squamous Non-Small Cell Lung Carcinoma

Subjects
Clinical trials, Mesothelioma -- Care and treatment, Medical research, Carcinoma -- Care and treatment, Non-small cell lung cancer -- Care and treatment, Cisplatin -- Product development, Health
Abstract

By a News Reporter-Staff News Editor at Clinical Trials Week -- Polaris Group announced that the first patient has been dosed in its Phase 1 trial of ADI-PEG 20 in [...]

Published
2014

49. Findings on Nasopharyngeal Carcinoma Discussed by C.C. He and Co-Researchers (Management of intractable epistaxis in patients who received radiation therapy for nasopharyngeal carcinoma)

Subjects
Medical research, Medicine, Experimental, Antineoplastic agents, Nosebleed -- Care and treatment, Radiation, Carcinoma -- Care and treatment, Cancer -- Care and treatment, Radiotherapy, Antimitotic agents, Health
Abstract

By a News Reporter-Staff News Editor at Hematology Week -- New research on Oncology is the subject of a report. According to news reporting originating in Nanning, People's Republic of [...]

Published
2014

50. Should patients with Merkel cell carcinoma be treated with postoperative adjuvant therapy? Studies point to greater survival with radiation

Author

Olbricht, Suzanne M.

Subjects
Carcinoma -- Care and treatment, Cancer -- Care and treatment, Radiotherapy, Medical research, Medicine, Experimental, Health, Health care industry
Abstract

Survival and recurrence rates for patients with Merkel cell carcinoma (MCC) are not good with surgical treatment alone. Without further treatment after surgery, the cancer locally recurs in 26%-44% of [...]

Published
2007

Catalog

Books, media, physical & digital resources
See catalog results